netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Results

Looking for Dupilumab found 10 matches
Open monograph to display formulary status BNF Category
  Dupilumab  (Dupixent®) Skin - Drugs affecting the immune response - 13.05.03
  Lebrikizumab  (Ebglyss®) Skin - Drugs affecting the immune response - 13.05.03
  Tralokinumab  (Adtralza ®) Skin - Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA: Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management (13.05.03)
link in drug section MHRA: Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management (13.05.03)
link in drug section MHRA: Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management (03.04.02)
link in drug section MHRA: Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management (13.05.03)
link in drug section NICE TA534: Dupilumab for treating moderate to severe atopic dermatitis (13.05.03)
link in drug section NICE TA751: Dupilumab for treating severe asthma with type 2 inflammation (03.04.02)
link in drug section NICE TA955: Dupilumab for treating moderate to severe prurigo nodularis (13.05.03)




Document Library Items Found

 
netFormulary